Soni Manmeet Singh 4
4 · Summit Therapeutics Inc. · Filed Oct 23, 2025
Insider Transaction Report
Form 4
Soni Manmeet Singh
DirectorCOO and CFO
Transactions
- Award
Common Stock
2025-10-21$18.74/sh+53,361$999,985→ 3,073,603 total
Footnotes (1)
- [F1]Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.